ClearEdge3D has announced the availability of EdgeWise Plant, an as-built modeling platform that reduces potential errors associated with manual modeling techniques. The platform serves as an ...
Edgewise Therapeutics , Inc. (NASDAQ:EWTX), with a market capitalization of $2.67 billion, is a biopharmaceutical company focused on developing innovative therapies for severe, rare muscle disorders.
This press release contains forward-looking statements as that term is defined in Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. Statements in this ...
BOULDER, Colo.--(BUSINESS WIRE)--Edgewise Therapeutics, Inc. (Nasdaq: EWTX), a leading muscle disease biopharmaceutical company, today provided recent corporate updates and highlighted upcoming ...
Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Edgewise Therapeutics (EWTX – Research Report) and Cross Country Healthcare (CCRN – Research Report).
- Presenting at the 44 th Annual J.P. Morgan Healthcare Conference on Tuesday, January 13, 2026 at 8:15 am PT (11:15 am ET) - BOULDER, Colo., Jan. 13, 2026 /PRNewswire/ -- Edgewise Therapeutics, Inc., ...
- Presenting at the 44th Annual J.P. Morgan Healthcare Conference on Tuesday, January 13, 2026 at 8:15 am PT (11:15 am ET) - "2025 marked a year of disciplined execution and substantial advances in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results